The Budget 2018-2019: our three key areas for intellectual property

Biotechnology companies and generic pharmaceuticals are the winners and celebrities are the Biggest Losers in some intellectual property-related measures in last night’s Australian Federal Budget.  Below, we set out the three key areas of interest from our first reading. Swap it! Boost for generic and biosimilar awareness campaigns The Budget will fund measures to increase the use read more...
Subjects: Media